Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.62 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | ESR1 | P03372 | 2/20 | 0.52 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | NT5E | P21589 | 1/20 | 0.46 |
| ▸ | SNCA | P37840 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | HTR6 | P50406 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.36 |
| ▸ | PTPRA | P18433 | 1/20 | 0.36 |
| ▸ | PTPRB | P23467 | 1/20 | 0.36 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6569261 | 1.00 | TSHR (0.62) | TSHRSMN1; SMN2CYP2D6POLBTDP1 | |
| Water SCHEMBL1536886 | 0.98 | TSHR (0.60) | TSHRSMN1; SMN2CYP2D6POLBTDP1 | |
| Water SCHEMBL21570871 | 0.98 | TSHR (0.60) | TSHRSMN1; SMN2CYP2D6POLBTDP1 | |
| Water SCHEMBL1238257 | 0.98 | TSHR (0.60) | TSHRSMN1; SMN2CYP2D6POLBTDP1 | |
| SCHEMBL996850 | 0.98 | TSHR (0.65) | TSHRSMN1; SMN2CYP2D6POLBTDP1 | |
| SCHEMBL718256 | 0.98 | TSHR (0.65) | TSHRSMN1; SMN2CYP2D6POLBTDP1 | |
| SCHEMBL6568428 | 0.96 | TSHR (0.62) | TSHRSMN1; SMN2CYP2D6POLBTDP1 | |
| Potassium SCHEMBL1450612 | 0.96 | TSHR (0.62) | TSHRSMN1; SMN2CYP2D6POLBTDP1 | |
| SCHEMBL8145540 | 0.96 | TSHR (0.62) | TSHRSMN1; SMN2CYP2D6POLBTDP1 | |
| Water SCHEMBL570669 | 0.96 | TSHR (0.62) | TSHRSMN1; SMN2CYP2D6POLBTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9527737-B2 | Carbon nanotube manufacturing method | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2016-12-27 | — | — | US | disclosed |
| US-9481618-B2 | Cyclopolyarylene compound and method of manufacturing same | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2016-11-01 | — | — | US | disclosed |
| EP-2610248-B1 | METHOD FOR PRODUCING PHENYL-SUBSTITUTED HETEROCYCLIC DERIVATIVE BY MEANS OF COUPLING METHOD USING A PALLADIUM COMPOUND | TEIJIN PHARMA LTD (JP) | 2016-06-08 | — | — | EP | disclosed |
| US-9266909-B2 | Cyclic compound containing functional group or containing no functional group, and method for producing same | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2016-02-23 | — | — | US | disclosed |
| US-20150126779-A1 | CYCLIC COMPOUND CONTAINING FUNCTIONAL GROUP OR CONTAINING NO FUNCTIONAL GROUP, AND METHOD FOR PRODUCING SAME | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2015-05-07 | — | — | US | disclosed |
| US-8952174-B2 | Process for producing phenyl-substituted heterocyclic derivative through coupling using transition metal catalyst | TEIJIN PHARMA LIMITED (JP) | 2015-02-10 | — | — | US | disclosed |
| US-8916714-B2 | Method for producing phenyl-substituted heterocyclic derivative by means of coupling method using palladium compound | TEIJIN PHARMA LIMITED (JP) | 2014-12-23 | — | — | US | disclosed |
| US-20140066661-A1 | CYCLOPOLYARYLENE COMPOUND AND METHOD OF MANUFACTURING SAME | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2014-03-06 | — | — | US | disclosed |
| US-20140030183-A1 | CARBON NANOTUBE MANUFACTURING METHOD | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2014-01-30 | — | — | US | disclosed |
| EP-2684844-A1 | CARBON NANOTUBE MANUFACTURING METHOD | National University Corporation Nagoya University (JP) | 2014-01-15 | — | — | EP | disclosed |
| US-20130324768-A1 | CARBON NANORING AND METHOD FOR PRODUCING A RING-SHAPED COMPOUND SUITABLE AS A STARTING MATERIAL FOR PRODUCTION OF THE SAME | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2013-12-05 | — | — | US | disclosed |
| EP-2610248-A1 | METHOD FOR PRODUCING PHENYL-SUBSTITUTED HETEROCYCLIC DERIVATIVE BY MEANS OF COUPLING METHOD USING A PALLADIUM COMPOUND | Teijin Pharma Limited (JP) | 2013-07-03 | — | — | EP | disclosed |
| US-20130158272-A1 | METHOD FOR PRODUCING PHENYL-SUBSTITUTED HETEROCYCLIC DERIVATIVE BY MEANS OF COUPLING METHOD USING PALLADIUM COMPOUND | TEIJIN PHARMA LIMITED (JP) | 2013-06-20 | — | — | US | disclosed |
| EP-2546219-A1 | CARBON NANORING AND METHOD FOR PRODUCING A RING-SHAPED COMPOUND SUITABLE AS A STARTING MATERIAL FOR PRODUCTION OF THE SAME | National University Corporation Nagoya University (JP) | 2013-01-16 | — | — | EP | disclosed |
| EP-2404908-A1 | PROCESS FOR PRODUCING PHENYL-SUBSTITUTED HETEROCYCLIC DERIVATIVE THROUGH COUPLING USING TRANSITION METAL CATALYST | Teijin Pharma Limited (JP) | 2012-01-11 | — | — | EP | disclosed |
| US-20110313169-A1 | PROCESS FOR PRODUCING PHENYL-SUBSTITUTED HETEROCYCLIC DERIVATIVE THROUGH COUPLING USING TRANSITION METAL CATALYST | TEIJIN PHARMA LIMITED (JP) | 2011-12-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140066661-A1 | CYCLOPOLYARYLENE COMPOUND AND METHOD OF MANUFACTURING SAME | CYP1B1, CYP51A1, CYP1A1 | TSHR 4238/4885SMN1; SMN2 2145/4885CYP2D6 64/4885 |
| US-20110313169-A1 | PROCESS FOR PRODUCING PHENYL-SUBSTITUTED HETEROCYCLIC DERIVATIVE THROUGH COUPLING USING TRANSITION METAL CATALYST | XDH, PAH, HPRT1 | TSHR 3099/4885SMN1; SMN2 3876/4885CYP2D6 185/4885 |
| US-20130324768-A1 | CARBON NANORING AND METHOD FOR PRODUCING A RING-SHAPED COMPOUND SUITABLE AS A STARTING MATERIAL FOR PRODUCTION OF THE SAME | CBR1, CBR3, CYC1 | TSHR 4066/4885SMN1; SMN2 3729/4885CYP2D6 749/4885 |
| US-20150126779-A1 | CYCLIC COMPOUND CONTAINING FUNCTIONAL GROUP OR CONTAINING NO FUNCTIONAL GROUP, AND METHOD FOR PRODUCING SAME | CYP1B1, BCR, DDT | TSHR 3884/4885SMN1; SMN2 4880/4885CYP2D6 404/4885 |
| US-20130158272-A1 | METHOD FOR PRODUCING PHENYL-SUBSTITUTED HETEROCYCLIC DERIVATIVE BY MEANS OF COUPLING METHOD USING PALLADIUM COMPOUND | XDH, AOC1, PAH | TSHR 3154/4885SMN1; SMN2 3766/4885CYP2D6 131/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.